Literature DB >> 33499377

A Machine Learning-Based Investigation of Gender-Specific Prognosis of Lung Cancers.

Yueying Wang1, Shuai Liu2, Zhao Wang2, Yusi Fan2, Jingxuan Huang2, Lan Huang2, Zhijun Li1, Xinwei Li1, Mengdi Jin1, Qiong Yu1, Fengfeng Zhou2.   

Abstract

BACKGROUND AND
OBJECTIVE: Primary lung cancer is a lethal and rapidly-developing cancer type and is one of the most leading causes of cancer deaths.
MATERIALS AND METHODS: Statistical methods such as Cox regression are usually used to detect the prognosis factors of a disease. This study investigated survival prediction using machine learning algorithms. The clinical data of 28,458 patients with primary lung cancers were collected from the Surveillance, Epidemiology, and End Results (SEER) database.
RESULTS: This study indicated that the survival rate of women with primary lung cancer was often higher than that of men (p < 0.001). Seven popular machine learning algorithms were utilized to evaluate one-year, three-year, and five-year survival prediction The two classifiers extreme gradient boosting (XGB) and logistic regression (LR) achieved the best prediction accuracies. The importance variable of the trained XGB models suggested that surgical removal (feature "Surgery") made the largest contribution to the one-year survival prediction models, while the metastatic status (feature "N" stage) of the regional lymph nodes was the most important contributor to three-year and five-year survival prediction. The female patients' three-year prognosis model achieved a prediction accuracy of 0.8297 on the independent future samples, while the male model only achieved the accuracy 0.7329.
CONCLUSIONS: This data suggested that male patients may have more complicated factors in lung cancer than females, and it is necessary to develop gender-specific diagnosis and prognosis models.

Entities:  

Keywords:  gender; lung cancer; machine learning; prognosis; survival prediction

Mesh:

Year:  2021        PMID: 33499377      PMCID: PMC7911834          DOI: 10.3390/medicina57020099

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  55 in total

1.  Precystectomy nomogram for prediction of advanced bladder cancer stage.

Authors:  Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark Schoenberg; Seth P Lerner
Journal:  Eur Urol       Date:  2006-06-23       Impact factor: 20.096

2.  Analysis of clinical features and prognostic factors of lung cancer patients: A population-based cohort study.

Authors:  Yuan Gao; Xinjia Zhou
Journal:  Clin Respir J       Date:  2020-03-19       Impact factor: 2.570

3.  Differences in lung cancer risk between men and women: examination of the evidence.

Authors:  E A Zang; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

Review 4.  Gender discrepancies in bladder cancer: potential explanations.

Authors:  Pravin Viswambaram; Dickon Hayne
Journal:  Expert Rev Anticancer Ther       Date:  2020-09-08       Impact factor: 4.512

5.  First-Trimester Prognosis When an Early Gestational Sac is Seen on Ultrasound Imaging: Logistic Regression Prediction Model.

Authors:  Peter M Doubilet; Catherine H Phillips; Sara M Durfee; Carol B Benson
Journal:  J Ultrasound Med       Date:  2020-08-11       Impact factor: 2.153

6.  Automatic emphysema detection using weakly labeled HRCT lung images.

Authors:  Isabel Pino Peña; Veronika Cheplygina; Sofia Paschaloudi; Morten Vuust; Jesper Carl; Ulla Møller Weinreich; Lasse Riis Østergaard; Marleen de Bruijne
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

Review 7.  Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review.

Authors:  Alessia Sarica; Antonio Cerasa; Aldo Quattrone
Journal:  Front Aging Neurosci       Date:  2017-10-06       Impact factor: 5.750

8.  Blood-based FTIR-ATR spectroscopy coupled with extreme gradient boosting for the diagnosis of type 2 diabetes: A STARD compliant diagnosis research.

Authors:  Peiwen Guang; Wendong Huang; Liu Guo; Xinhao Yang; Furong Huang; Maoxun Yang; Wangrong Wen; Li Li
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.889

9.  Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.

Authors:  Jianjie Li; Qiwen Zheng; Xinghui Zhao; Jun Zhao; Tongtong An; Meina Wu; Yuyan Wang; Minglei Zhuo; Jia Zhong; Xue Yang; Bo Jia; Hanxiao Chen; Zhi Dong; Jingjing Wang; Yujia Chi; Xiaoyu Zhai; Ziping Wang
Journal:  BMC Cancer       Date:  2020-08-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.